Imaging News

Among patients with stable ischemic heart disease enrolled in the ISCHEMIA trial, those with chronic total occlusion lesions had similar outcomes compared with those who did not.

In the general Swedish population, 4 in 10 middle-aged adults have silent CAD and 1 in 20 have severe CAD on coronary CT angiography, according to new data from the Swedish Cardiopulmonary Bioimage Study.

With advances across multiple imaging modalities, decision-making regarding the optimal test for the evaluation of CAD can be challenging. However, the role of coronary CT angiography has become more important in the wake of recent trials.

Mitral valve replacement using a novel transfemoral implantation system was successful in patients with severe mitral regurgitation at high surgical risk, according to findings presented at the virtual TCT Connect.

In patients undergoing PCI with a drug-eluting stent, those whose procedures were guided by IVUS had less target vessel failure at 3 years than those whose procedures were guided by angiography, new data from the ULTIMATE trial showed.

Among patients with nonflow-limiting vulnerable plaques, PCI with a bioresorbable vascular scaffold was safe and was linked to favorable long-term outcomes, according to the pilot PROSPECT ABSORB trial presented at the virtual TCT Connect.

Fetal echocardiograms for low-risk pregnancies have been reduced during the COVID-19 pandemic, which may bring about a need for fetal tele-echocardiography, according to a review published in Progress in Pediatric Cardiology.

In heart transplant recipients, PCSK9 inhibitors lowered LDL, stabilized coronary intimal hyperplasia and were associated with minimal adverse effects, according to data from the virtual Heart Failure Society of America Scientific Meeting.

Transendocardial administration of allogenic bone marrow-derived mesenchymal stromal cells may benefit patients with anthracycline-induced cardiomyopathy, according to a phase 1 study.

Sacubitril/valsartan failed to demonstrate significant reverse remodeling effect compared with valsartan among patients with asymptomatic left ventricular systolic dysfunction following MI, a speaker reported.